Mathews Publishes open access journals where the published articles are freely available online to all the interested readers around the globe and disseminating the information without any hindrance. Mathews Publications is a self-supporting organization and do not receive any funding from agencies or supporting organizations. The only way to meet the operations cost is Article Processing Charges (APCs) from authors. However, scientific innovations and researches can submit without any paid subscription. Processing charges allow the publisher to make articles immediately available online, cover the cost of editorial work, editing, plagiarism check, typesetting, and permanent online archiving. The APCs will be billed to the submitting author or corresponding author upon acceptance of the article.
The processing charges for a single manuscript are 1539 USD.
Withdrawal Policy
Withdrawal request generally is wastage of precious resources including editors, reviewers, and the editorial staff unless there are unavoidable reasons. The author is allowed to withdraw the manuscript without paying any withdrawal fees within 48 hours of submission. If the author(s) requests a withdrawal of manuscript, after the peer review process or in the production stage then authors are liable to pay withdrawal charges.
Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.
Published : 11th December 2023
Authors : Aria Hajihassan1, Atena Zandi1, Ghazal Esmaeili1, Mostafa Norizadeh2,3,*
Citation : Hajihassan A, et al. (2023). Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews J Pharma Sci. 7(4):25.
Published : 25th November 2023
Authors : Qadeer Ahmed, Muhammad Talha, Umer Ishtiaq, Saba Khurshid, Kaif Akbar, Urwa Amir, Muhammad Rehan, Ovais Ullah Shirazi, Shahid Latif, Zunaira Akbar, Iram Batool, Ali Akhtar*, Samreen Fatima
Citation : Ahmed Q, et al. (2023). Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients. Mathews J Pharma Sci. 7(4):24.
Published : 03rd November 2023
Authors : Dadier Antonio Arroyo1,2,*, Linda Atencio1, Jorge Pérez Velásquez3, María Camila Coronado1, Meribeth Henry4, Maria Alejandra Suarez2, Daniela Katerine Rivera2
Citation : Arroyo DA, et al. (2023). Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report. Mathews J Pharma Sci. 7(3):23.
Published : 17th October 2023
Author : Raúl Isea*
Citation : Isea R. (2023). We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21st Century. Mathews J Pharma Sci. 7(3):22.
Published : 11th October 2023
Authors : Allen B Richon1,*, Merry Ambos Richon2
Citation : Richon AB, et al. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews J Pharma Sci. 7(3):21.